Overview of Vitiligo Research April - June 2013
This is a review of research results in the vitiligo field which were indexed in the PubMed database (www.ncbi.nlm.nih.gov/pubmed) for the period from April 2013 till June 2013. Abstracts of papers were retrieved from the PubMed database using the search term “vitiligo” with a filter set up to retrieve records with creation date between April 01, 2013 and June 30, 2013. Retrieved records were manually checked for a relevance to and significance for the field of vitiligo research. Fifty six records have been selected for inclusion into this quarterly overview.
- Experimental data suggest that vitiligo might be considered as a degenerative disease
- MIA protein can be involved in stress-induced melanocyte loss in vitiligo
- Revealed crucial role of BACH2 in shaping regulatory T-cell response in conjunction with association of BACH2 genetic variations with vitiligo support regulatory T-cell involvement in vitiligo pathogenesis and opens an avenue for exploring mechanisms of regulatory T-cell
- Two new mouse models of vitiligo have been developed
- Luteolin may be beneficial in vitiligo treatment
- Dermal mesenchymal stem cells can help in autologous melanocyte transplantation
- Dermal fibroblast subpopulation can be used as a source for generation of functional melanocytes
- Wnt signaling pathway emerges as a target to promote repigmentation from hair follicle
- Childhood vitiligo relapse rate after successful stopping vitiligo progression with systemic steroids is 34.8% within 1 year thus warranting development of preventive strategies
- History of atopic disorders might predict extent of vitiligo.
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
NY Vitiligo Community Meeting in September
Our next meeting will be on Thursday, September 21st, at 7PM - 8:30PM on the 11th floor of NYU's Ambulatory Care Center at 240 East 38th Street, between 2nd and 3rd Av...21 September 2017 19:00, 11th floor of NYU's Ambulatory Car...
Vitiligo Advocacy Day at the US Capitol
Save-the-Date for the much anticipated Vitiligo Advocacy Day at the United States Capitol this fall. As many of you know, the Advocacy Committee of the Global Vitilig...04 October 2017 10:00, Washington, DC
What causes vitiligo?
The precise cause of vitiligo is not well understood. The white areas appear due to loss of the pigment (melanin) that gives skin its color and protects it from the su...
How can I cure vitiligo?
There is no cure for vitiligo, but there are a number of effective treatment options that can be discussed with your GP or dermatologist. The aim of treatment is to st...
Can chemicals cause vitiligo?
Yes, certain chemicals can, indeed, induce or worsen vitiligo. Most commonly they include phenols, such as 4-tertiary-butyl phenol (4-TBP, found in adhesives) or 4-ter...
Can Scenesse be used for vitiligo treatment?
The drug Scenesse from Clinuvel has been tested in clinical trials in relation vitiligo. Profs. Henry Lim, Mark Lebwohl and coauthors reported (PubMed) results of mult...